The estimated Net Worth of Advisors Llc Orbi Med Capit... is at least $119 million dollars as of 8 December 2017. Advisors Capit owns over 250,000 units of Rhythm Pharmaceuticals stock worth over $46,400,710 and over the last 9 years Advisors sold RYTM stock worth over $72,774,425.
Advisors has made over 15 trades of the Rhythm Pharmaceuticals stock since 2015, according to the Form 4 filled with the SEC. Most recently Advisors sold 250,000 units of RYTM stock worth $20,625,000 on 8 December 2017.
The largest trade Advisors's ever made was buying 1,712,400 units of Rhythm Pharmaceuticals stock on 20 May 2016 worth over $17,843,208. On average, Advisors trades about 328,195 units every 52 days since 2015. As of 8 December 2017 Advisors still owns at least 941,000 units of Rhythm Pharmaceuticals stock.
You can see the complete history of Advisors Capit stock trades at the bottom of the page.
Over the last 13 years, insiders at Rhythm Pharmaceuticals have traded over $83,445,563 worth of Rhythm Pharmaceuticals stock and bought 6,290,000 units worth $106,961,700 . The most active insiders traders include Forest Baskett, Scott D Sandell et Peter J Barris. On average, Rhythm Pharmaceuticals executives and independent directors trade stock every 17 days with the average trade being worth of $3,358,405. The most recent stock trade was executed by Pamela J. Cramer on 9 September 2024, trading 4,099 units of RYTM stock currently worth $77,963.
rhythm pharmaceuticals inc. is a biotechnology company located in 855 boylston street, 11th floor, boston, ma, united states.
Rhythm Pharmaceuticals executives and other stock owners filed with the SEC include: